Shandong Weigao Blood Purification (603014.SH) and Terumo China Plan Proportional Capital Increase in Weigao Terumo

Stock News11-20

Shandong Weigao Blood Purification Products Co., Ltd. (603014.SH) announced that, in line with its strategic planning and to support the development of its peritoneal dialysis fluid business, the company and Terumo China intend to conduct a proportional capital increase in their joint venture, Weigao Terumo. Weigao Blood Purification plans to invest an additional RMB 72.5 million.

Upon completion of the capital injection, Weigao Terumo's registered capital will rise from RMB 160 million to RMB 305 million. Shandong Weigao Blood Purification will maintain its 50% stake in the joint venture, which remains under the shared control of both companies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187173107?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-20 17:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187173107","market":"us","top_or_hot":-1,"title":"Shandong Weigao Blood Purification (603014.SH) and Terumo China Plan Proportional Capital Increase in Weigao Terumo","media":"Stock News","content":"<p>Shandong Weigao Blood Purification Products Co., Ltd. (603014.SH) announced that, in line with its strategic planning and to support the development of its peritoneal dialysis fluid business, the company and Terumo China intend to conduct a proportional capital increase in their joint venture, Weigao Terumo. Weigao Blood Purification plans to invest an additional RMB 72.5 million.</p>\n<p>Upon completion of the capital injection, Weigao Terumo's registered capital will rise from RMB 160 million to RMB 305 million. Shandong Weigao Blood Purification will maintain its 50% stake in the joint venture, which remains under the shared control of both companies.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Weigao Blood Purification (603014.SH) and Terumo China Plan Proportional Capital Increase in Weigao Terumo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Weigao Blood Purification (603014.SH) and Terumo China Plan Proportional Capital Increase in Weigao Terumo\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-20 17:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Blood Purification Products Co., Ltd. (603014.SH) announced that, in line with its strategic planning and to support the development of its peritoneal dialysis fluid business, the company and Terumo China intend to conduct a proportional capital increase in their joint venture, Weigao Terumo. Weigao Blood Purification plans to invest an additional RMB 72.5 million.</p>\n<p>Upon completion of the capital injection, Weigao Terumo's registered capital will rise from RMB 160 million to RMB 305 million. Shandong Weigao Blood Purification will maintain its 50% stake in the joint venture, which remains under the shared control of both companies.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603014","symbol_name":"威高血净","start_time":0,"source_url":"","article_id":"1187173107","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187173107","pubTimestamp":1763630190,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shandong Weigao Blood Purification Products Co., Ltd. (603014.SH) announced that, in line with its strategic planning and to support the development of its peritoneal dialysis fluid business, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603014":"威高血净","BK0251":"专用设备"},"translate_title":"山东威高血液净化（603014.SH）与泰尔茂中国拟按比例增资威高泰尔茂","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603014":1},"content_text":"Shandong Weigao Blood Purification Products Co., Ltd. (603014.SH) announced that, in line with its strategic planning and to support the development of its peritoneal dialysis fluid business, the company and Terumo China intend to conduct a proportional capital increase in their joint venture, Weigao Terumo. Weigao Blood Purification plans to invest an additional RMB 72.5 million.\nUpon completion of the capital injection, Weigao Terumo's registered capital will rise from RMB 160 million to RMB 305 million. Shandong Weigao Blood Purification will maintain its 50% stake in the joint venture, which remains under the shared control of both companies.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187173107","isCrawlerRequest":true}